Core Viewpoint - Haleon, after its spin-off from GSK, has successfully navigated market challenges and achieved significant growth in the Chinese market, becoming a standout performer globally [3][5][30] Group 1: Company Overview and Leadership - Haleon was established as a separate entity from GSK in July 2022, inheriting well-known brands like Caltrate and Sensodyne, and has since focused on building a new operational identity [3][5] - The company has seen its market share increase for 54 consecutive months, indicating strong performance in a competitive landscape [3] - Gu Haiying, the General Manager for Mainland China and Hong Kong, emphasizes the importance of leadership and adaptability during periods of transformation [7][8] Group 2: Employee Engagement and Culture - Haleon's employee engagement index has ranked first among its global markets for three consecutive years, reflecting a strong corporate culture [10] - The company prioritizes both "hardware" (systems and processes) and "software" (team cohesion and culture) in its transformation efforts [12] - A focus on communication, trust, and teamwork has been pivotal in unifying the workforce during the integration and spin-off phases [12][13] Group 3: Strategic Initiatives and Market Position - Haleon has positioned China as one of its two "winning markets," implementing a localized decision-making strategy to enhance operational effectiveness [17][18] - The full acquisition of its OTC joint venture marks a significant milestone, allowing for complete control over its operations in China [19][22] - The company is committed to sustainable practices, achieving carbon neutrality in its Suzhou factory and implementing eco-friendly packaging initiatives [24][26] Group 4: Future Directions and Innovations - Haleon is focusing on digital transformation and AI integration, with plans to enhance operational efficiency and product development through technology [28][30] - The company aims to leverage AI not just for cost reduction but to empower and enhance workforce capabilities [28] - Looking ahead, Haleon sees significant opportunities in increasing market penetration in the consumer health sector, addressing gaps in disease occurrence and treatment rates [30]

Core Insights - The 8th China International Import Expo (CIIE) is being held in Shanghai from November 5 to 10, showcasing global health and nutrition trends through partnerships with nine renowned health brands [1] - JD Health is leveraging its platform to introduce cutting-edge health products and research findings to Chinese consumers, enhancing the national health landscape [1] Group 1: Strategic Partnerships - JD Health signed a strategic cooperation agreement with GNC to enhance cardiovascular health initiatives and establish high industry standards [1] - A collaboration with the international vitamin brand Centrum aims to create a "Brain Vitamin White Paper" to advance brain health through a comprehensive ecosystem of research, products, and scenarios [2] - JD Health is deepening its partnership with Homart Group to develop integrated solutions tailored to Chinese consumer needs based on insights and nutritionist services [2] Group 2: Product Launches and Innovations - JD Health and NYO3 released a "Krill Oil Health Science White Paper" to educate consumers on krill oil benefits, alongside launching three anti-aging products [2] - In the youth nutrition sector, JD Health partnered with inne to establish "Calcium Quality Standards" for children's calcium supplements, ensuring quality and safety for parents [2] - The company is set to launch new products like "Academic DHA" and "Youth Vision" in collaboration with leading children's nutrition brands [3] Group 3: Market Positioning - JD Health aims to act as a bridge between global premium brands and the Chinese market, enhancing consumer access to high-quality nutrition products [3] - The company emphasizes its supply chain and platform advantages to continuously gather global scientific nutrition products for Chinese consumers [3]

Group 1 - Nearly 70% of British companies in China are optimistic about their business prospects over the next 5 to 10 years and plan to increase investments in China [1][6] - The UK is China's second-largest trading partner after the US, highlighting the importance of the Chinese market for global brands [3][6] - The shift in Chinese consumer behavior from "purchasing" to "experiencing" brands emphasizes the need for companies to focus on the experiential aspect of their products [3][5] Group 2 - The presence of social media has simplified market entry for companies, allowing them to focus on online platforms rather than traditional brick-and-mortar stores [4][5] - The Chinese government has implemented policies to boost domestic consumption and reduce market entry barriers, which are beneficial for foreign businesses [5][6] - The UK-China trade relationship is characterized by strong complementarity, with the UK being a significant investment destination for Chinese companies [6][8] Group 3 - The UK government has suspended tariffs on 89 products to alleviate the burden on businesses, which is expected to save around £17 million annually [7] - The British market, while smaller than China's, remains vibrant and open, providing opportunities for international brands [6][7] - The British Chamber of Commerce is actively working to assist small and medium-sized enterprises (SMEs) in entering the Chinese market [6]